06 September 2013 6 9K Report

A wide variety of synthetic cannabinoids (SC) are now being marketed as "safer" or "quasi legal" alternatives to plant cannabis.

Anecdotally, it appears that these research chemicals are typically associated with a significantly higher risk of acute adverse responses (such as tachycardia, anxiety attacks and transient psychosis) than smoking "real" plant cannabis.

As the majority of SC products being marketed contain chemicals that are much stronger cannabinoid receptor ligands than THC, (and some contain mixtures of more than one SC), and as these mixtures do not contain any equivalent to CBD, this is perhaps not surprising.

Does anyone know of animal studies or case histories relevant to the potential of these chemicals to induce such acute problems?

I am also keen to find any research that may indicate the potential for dependence, and likely withdrawal profiles upon abrupt abstinence from regular use, of these chemicals.

>

“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report

http://onlinelibrary.wiley.com/doi/10.1002/hup.2312/abstract

.

Thanks.

More Paul Dessauer's questions See All
Similar questions and discussions